U. S. Securities and Exchange Commission
                         Washington, D. C.  20549


                                FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarterly period ended September 30, 2004

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from                to
                                    --------------    ---------------

                     Commission File No.  000-31377

                          REFLECT SCIENTIFIC, INC.
                          ------------------------
             (Name of Small Business Issuer in its Charter)


             UTAH                                      87-0642556
             ----                                      ----------
  (State or Other Jurisdiction of              (I.R.S. Employer I.D. No.)
   incorporation or organization)

                          970 Terra Bella Avenue
                     Mountain View, California, 94043
                     --------------------------------
                  (Address of Principal Executive Offices)

            Issuer's Telephone Number:  (650) 960-0300

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

(1)  Yes  X     No                 (2)  Yes  X    No
         ---     ---                        ---     ---

<PAGE>
             APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                PROCEEDINGS DURING THE PRECEDING FIVE YEARS

                              Not applicable.


                   APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the Registrant's classes
of common stock, as of the latest practicable date:

                            September 30, 2004

                        Common Stock - 24,000,000
                        -------------------------

                      PART I - FINANCIAL INFORMATION


Item 1.   Financial Statements.
-------------------------------

          The Financial Statements of the Company required to be filed with
this 10-QSB Quarterly Report were prepared by management, and commence on the
following page, together with Related Notes.  In the opinion of management,
the Financial Statements fairly present the financial condition of the
Company.
<PAGE>
                    REFLECT SCIENTIFIC, INC.

                CONSOLIDATED FINANCIAL STATEMENTS

            September 30, 2004 and December 31, 2003
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
                   Consolidated Balance Sheets

                              ASSETS

                                            September 30,       December 31,
                                                2004                2003
                                             (Unaudited)
<S>                                          <C>               <C>
CURRENT ASSETS

     Cash                                     $    34,668      $    99,924
     Accounts receivable, net                     319,129          232,464
     Inventory, net                               241,525          210,447
     Prepaid expenses                                 800              800
                                              -----------      -----------
          Total Current Assets                    596,122          543,635
                                              -----------      -----------
FIXED ASSETS (NET)                                 20,247           21,923
                                              -----------      -----------
OTHER ASSETS

     Deposits                                       5,350            5,350
     Capitalized loan costs, net                    5,775            6,125
                                              -----------      -----------
          Total Other Assets                       11,125           11,475
                                              -----------      -----------
          TOTAL ASSETS                        $   627,494      $   577,033
                                              ===========      ===========
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                2
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
             Consolidated Balance Sheets (Continued)


               LIABILITIES AND SHAREHOLDERS' EQUITY

                                            September 30,        December 31,
                                                2004                2003
                                             (Unaudited)
<S>                                          <C>               <C>
CURRENT LIABILITIES

     Accounts payable                         $    161,228     $    199,375
     Accrued expenses                               27,201           15,179
                                              ------------     ------------
          Total Current Liabilities                188,429          214,554
                                              ------------     ------------
NON-CURRENT LIABILITIES

     Long term line of credit                      268,985          269,011
                                              ------------     ------------
          Total Non-Current Liabilities            268,985          269,011
                                              ------------     ------------
          Total Liabilities                        457,414          483,565
                                              ------------     ------------
COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY

     Preferred stock, $0.01 par value, authorized
     5,000,000 shares; no issued or outstanding
     shares                                              -                -
     Common stock, $0.01 par value, authorized
     50,000,000 shares; 24,000,000 shares
     issued and outstanding                        240,000          240,000
     Additional paid-in capital (deficit)         (188,319)        (210,841)
     Retained earnings                             118,399           64,309
                                             -------------     ------------
          Total Shareholders' Equity               170,080           93,468
                                             -------------     ------------
          TOTAL LIABILITIES AND SHAREHOLDERS'
          EQUITY                             $     627,494     $    577,033
                                             =============     ============
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                3
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Operations
                           (Unaudited)


                          For the Three Months Ended For the Nine Months Ended
                               September 30,               September 30,
                           2004                2003     2004            2003
<S>                           <C>           <C>         <C>       <C>
REVENUES                    $ 522,600     $ 457,067   $ 1,604,307 $ 1,425,762

COST OF GOODS SOLD            319,435       254,829       963,470     854,396
                             --------     ---------   ----------- -----------
GROSS PROFIT                  203,165       202,238       640,837     571,366
                             --------     ---------   ----------- -----------
OPERATING EXPENSES

     Salaries and wages        87,091        70,137       263,273     230,007
     Payroll taxes              7,127         5,920        22,558      19,644
     Rent expense              19,306        18,870        57,364      56,596
     General and
      administrative expense   88,124        35,374       226,292      93,526
                             --------     ---------   ----------- -----------
   Total Operating Expenses   201,648       130,301       569,487     399,773
                             --------     ---------   ----------- -----------
OPERATING INCOME                1,517        71,937        71,350     171,593
                             --------     ---------   ----------- -----------
OTHER INCOME (EXPENSE)

     Sundry income                  -             -         5,000           -
     Miscellaneous income
      (expense)                     -             -          (301)          -
     Interest expense          (3,051)       (1,780)       (8,759)    (11,262)
                             --------     ---------   ----------- -----------
          Total Other Income
          (Expense)            (3,051)       (1,780)       (4,060)    (11,262)
                             --------     ---------   ----------- -----------
NET INCOME BEFORE INCOME TAX   (1,534)       70,157        67,290     160,331
                             --------     ---------   ----------- -----------
INCOME TAX EXPENSE                  -             -        13,200           -

NET INCOME                   $ (1,534)    $  70,157   $    54,090 $   160,331
                             ========     =========   =========== ===========
EARNINGS PER SHARE           $   0.00     $    0.00   $      0.00 $      0.01
                             ========     =========   =========== ===========
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING         24,000,000    22,914,949    24,000,000  22,914,949
                           ==========    ==========   =========== ===========
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                4
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
         Consolidated Statements of Shareholders' Equity


                                                        Additional
                      Common Stock     Preferred Stock   Paid-in    Retained
                    Shares      Amount  Shares  Amount   Capital    Earnings
<S>                <C>         <C>     <C>     <C>     <C>          <C>
Balance, December
31, 2001           22,914,949  $ 10,000     - $    -    $     -   $    83,619

Dividend                    -         -     -      -          -       (63,000)

Net income for
the year ended
December  31, 2002          -         -     -      -          -       141,018
                   ----------  -------- ----  ------    -------   -----------
Balance, December
31, 2002           22,914,949    10,000    -       -          -       161,637

Dividend                    -         -    -       -          -      (156,000)

Contributed Capital         -         -    -       -     26,950             -

Recapitalization
(Note 2)            1,085,051   230,000    -       -   (237,791)            -

Net income for the
year ended
December 31, 2003           -         -    -       -          -        58,672
                   ----------  -------- ----  ------  ---------   -----------
Balance, December
31, 2003           24,000,000   240,000    -       -   (210,841)       64,309

Contributed capital
(unaudited)                 -         -    -       -     22,522             -

Net income for the
nine months ended
September 30, 2004
(unaudited)                 -         -    -       -          -        54,090
                   ----------  -------- ----  ------  ---------    ----------
Balances, September
30, 2004
(unaudited)        24,000,000  $240,000    -  $    -  $(188,319)   $  118,399
                   ==========  ======== ====  ======  =========    ==========
</TABLE>

The accompanying notes are an integral part of these consolidated financial
statements.

                                5
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Cash Flows
                           (Unaudited)

                                                 For the
                                           Nine Months Ended
                                              September 30,
                                          2004                2003
<S>                                      <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES

     Net income                           $    54,090     $   160,331
     Adjustments to reconcile net income
      to net cash provided by operating
      activities:
          Depreciation                          1,676           1,776
          Amortization of capitalized loan
          costs                                   350             630
     Changes in operating assets and
     liabilities:
          (Increase) in accounts
          receivable                          (86,666)        (93,967)
          Decrease in prepaid expenses              -           6,124
          (Increase) decrease in inventory    (31,079)          5,988
          Increase (decrease) in accounts
          payable and accrued expenses        (26,124)         37,643
                                           ----------     -----------
               Net Cash Used by Operating
               Activities                     (87,753)        118,525

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of fixed assets                           -            (450)
                                           ----------     -----------
               Net Cash Used by Investing
              Activities                           -            (450)

CASH FLOWS FROM FINANCING ACTIVITIES

     Payments on short term lines of credit         -        (103,049)
     Change in long term line of credit           (25)        101,470
     Contributed capital                       22,522               -
     Distributions to sole shareholder              -        (101,000)
                                           ----------     -----------
               Net Cash Provided (Used) by
               Financing Activities            22,497        (102,579)
                                           ----------     -----------
NET INCREASE (DECREASE) IN CASH               (65,256)         15,496

CASH AT BEGINNING OF PERIOD                    99,924         115,644
                                           ----------     -----------
CASH AT END OF PERIOD                      $   34,668     $   131,140
                                           ==========     ===========

NON-CASH INVESTING AND FINANCING ACTIVITIES:

     Cash Paid For:

          Interest                         $    3,051     $    11,380
          Income taxes                     $        -     $         -

</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                6
<PAGE>
                    REFLECT SCIENTIFIC, INC.
          Notes to the Consolidated Financial Statements
             September 30, 2004 and December 31, 2003

NOTE 1 -  BASIS OF FINANCIAL STATEMENT PRESENTATION

     The accompanying unaudited condensed consolidated financial statements
     have been prepared by the Company pursuant to accounting principles
     generally accepted in the United States of America. Certain information
     and footnote disclosures normally included in financial statements
     prepared in accordance with accounting principles generally accepted in
     the United States of America have been condensed or omitted in
     accordance with such rules and regulations.  The information furnished
     in the interim condensed consolidated financial statements include
     normal recurring adjustments and reflects all adjustments, which, in the
     opinion of management, are necessary for a fair presentation of such
     financial statements.  Although management believes the disclosures and
     information presented are adequate to make the information not
     misleading, it is suggested that these interim condensed consolidated
     financial statements be read in conjunction with the Company's most
     recent audited consolidated financial statements and notes thereto
     included in its December 31, 2003 financial statements.  Operating
     results for the nine months ended September 30, 2004 are not necessarily
     indicative of the results that may be expected for the year ending
     December 31, 2004.

NOTE 2 -  ACQUISITION OF REFLECT SCIENTIFIC

     On December 30, 2003, pursuant to an agreement and plan of
     reorganization, the Company completed a reverse merger with the
     shareholder of Reflect Scientific, Inc. in which it acquired 100% of
     Reflect Scientific, Inc., a California Company in exchange for
     22,914,949 common shares of the Company.  The terms of the acquisition
     are detailed in an 8-K filing dated December 31, 2003.  Under the terms
     of the agreement, the President of Reflect Scientific, Inc. became the
     President of the Company and was elected to the Board of Directors, the
     acquisition was accounted for as a recapitalization of Reflect
     Scientific, Inc. because the members of Reflect Scientific, Inc.
     controlled the Company after the acquisition.  Reflect Scientific, Inc.
     was treated as the acquiring entity for accounting purposes and Cole,
     Inc. was the surviving entity for legal purposes.  There was no
     adjustment to the carrying values of the assets or liabilities of
     Reflect Scientific, Inc. and no goodwill was recorded.

                                7
<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.
--------------------------------------------------------------------

Results of Operations.
----------------------

          Our revenues increased during the quarter ended September 30, 2004,
to $522,600 from $457,067 for the quarter ended September 30, 2003, primarily
as a result of a general improvement in sales across several new product lines
and improving market conditions.

          Our cost of goods increased in the period ending September 30, 2004,
as compared to September 30, 2003, to $319,435 from $254,829.  The difference
was partly as a result of an increase in sales, increased raw material costs
and increased labor costs.

          General and administrative expenses increased to $88,124 during the
quarter ended September 30, 2004, from $35,374 during the quarter ended
September 30, 2003.  This increase was due to the addition of one full-time
employee, increased payroll and increased operational expenses, like legal and
accounting fees.

     Liquidity and Capital Resources.
     --------------------------------

          Our cash resources at September 30, 2004, were $34,668, with
accounts receivable of $319,129.  We have relied on revenues and lines of
credit for our cash resources.  At September 30, 2004, we had utilized
$268,985 of our $400,000 line of credit.  These funds should be adequate for
the next 12 months for continuing operations; however, plans for expansion
will require additional capital of between $500,000 and $750,000.

     Forward-Looking Statements.
     ---------------------------

         The Private Securities Litigation Reform Act of 1995 (the "Act")
provides a safe harbor for forward-looking statements made by or on behalf of
our Company.  Our Company and its representatives may from time to time make
written or oral statements that are "forward- looking," including statements
contained in this Quarterly Report and other filings with the Securities and
Exchange Commission and in reports to our Company's stockholders. Management
believes that all statements that express expectations and projections with
respect to future matters, as well as from developments beyond our Company's
control including changes in global economic conditions are forward-looking
statements within the meaning of the Act.  These statements are made on the
basis of management's views and assumptions, as of the time the statements are
made, regarding future events and business performance.  There can be no
assurance, however, that management's expectations will necessarily come to
pass.  Factors that may affect forward- looking statements include a wide
range of factors that could materially affect future developments and
performance, including the following:

         Changes in Company-wide strategies, which may result in changes in
the types or mix of businesses in which our Company is involved or chooses to
invest; changes in U.S., global or regional economic conditions, changes in
U.S. and global financial and equity markets, including significant interest
rate fluctuations, which may impede our Company's access to, or increase the
cost of, external financing for our operations and investments; increased
competitive pressures, both domestically and internationally, legal and
regulatory developments, such as regulatory actions affecting environmental
activities, the imposition by foreign countries of trade restrictions and
changes in international tax laws or currency controls; adverse weather
conditions or natural disasters, such as hurricanes and earthquakes, labor
disputes, which may lead to increased costs or disruption of operations.

         This list of factors that may affect future performance and the
accuracy of forward-looking statements is illustrative, but by no means
exhaustive.  Accordingly, all forward-looking statements should be evaluated
with the understanding of their inherent uncertainty.

Item 3. Controls and Procedures.
----------------------------------

          As of the end of the period covered by this Quarterly Report, we
carried out an evaluation, under the supervision and with the participation of
our President and Treasurer, of the effectiveness of our disclosure controls
and procedures.  Based on this evaluation, our President and Treasurer
concluded that our disclosure controls and procedures are effective in timely
alerting them to material information required to be included in our periodic
Securities and Exchange Commission reports.  It should be noted that the
design of any system of controls is based in part upon certain assumptions
about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future
conditions, regardless of how remote.  In addition, we reviewed our internal
controls over financial reporting, and there have been no changes in our
internal controls or in other factors in the last fiscal quarter that has
materially affected or is reasonably likely to materially affect our internal
control over financial reporting.

                        PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.
----------------------------

          None; not applicable.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.
----------------------------------------------------------------------

          None; not applicable.

Item 3.   Defaults Upon Senior Securities.
------------------------------------------

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.
--------------------------------------------------------------

          None; not applicable.

Item 5.   Other Information.
----------------------------

          November 9, 2004, we filed Articles of Amendment to our Articles of
Incorporation that designated 750,000 shares of our preferred stock as "2004
Series A Convertible Preferred Stock".  For a detailed description of the
rights, privileges and preferences of the 2004 Series A Convertible Preferred
Stock, see a copy of the Articles of Amendment that is attached hereto and
incorporated herein by reference as Exhibit 3.1.  See Item 6.

          We also have attached hereto and incorporated herein as Exhibit 3.2
an Amendment to our Bylaws that was adopted July 28, 2003.  See Item 6.

Item 6.   Exhibits and Reports on Form 8-K.
-------------------------------------------

          (a)  Exhibits.

               3.1    Articles of Amendment

               3.2    Amendment to Bylaws

               31.1   302 Certification of Kim Boyce

               31.2   302 Certification of Pamela Boyce

               32     906 Certification.

          (b)  Reports on Form 8-K.

               None.


                               SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                          REFLECT SCIENTIFIC, INC.

Date: 11/11/2004                          /s/Kim Boyce
                                          ------------------------------------
                                          Kim Boyce, President


Date: 11/11/2004                          /s/Pamela Boyce
                                          ------------------------------------
                                          Pamela Boyce, Secretary
<PAGE>